TY  - JOUR
AU  - Klimek, Ludger
AU  - Jutel, Marek
AU  - Akdis, Cezmi A
AU  - Bousquet, Jean
AU  - Akdis, Mübeccel
AU  - Torres, Maria J
AU  - Agache, Ioana
AU  - Canonica, G Walter
AU  - Del Giacco, Stefano
AU  - O'Mahony, Liam
AU  - Shamji, Mohamed H
AU  - Schwarze, Jürgen
AU  - Untersmayr, Eva
AU  - Ring, Johannes
AU  - Bedbrook, Anna
AU  - Worm, Margitta
AU  - Zuberbier, Torsten
AU  - Knol, Edward
AU  - Hoffmann-Sommergruber, Karin
AU  - Chivato, Tomás
PY  - 2021
DO  - 10.1111/all.14726
UR  - https://hdl.handle.net/10668/25389
T2  - Allergy
AB  - Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT162b2, several severe anaphylaxis cases occured within the first few days of public vaccination. An investigation is taking place to understand the cases and their triggers....
LA  - en
KW  - BNT162b2
KW  - COVID
KW  - SARS-CoV
KW  - anaphylaxis
KW  - mRNA
KW  - severe allergic reactions
KW  - vaccines
KW  - virus
KW  - BNT162 Vaccine
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Humans
KW  - SARS-CoV-2
KW  - Vaccines
TI  - ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
TY  - research article
VL  - 76
ER  -